Serum Lipid Profiles of Patients Taking Efavirenz-Based Antiretroviral Regimen Compared to Ritonavir-Boosted Atazanavir with an Optimized Background at Zewditu Memorial Hospital, Addis Ababa, Ethiopia

Serum Lipid Profiles of Patients Taking Efavirenz-Based Antiretroviral Regimen Compared to Ritonavir-Boosted Atazanavir with an Optimized Background at Zewditu Memorial Hospital, Addis Ababa, Ethiopia

Abebe Muche Belete,1 Daniel Seifu,2 Menakath Menon,3 Wondwossen Amogne,4 Aster Shewa,5 Alemu Adela Tefera1 1Department of Biochemistry, Medical Faculty, Debre Berhan University, Debre Berhan, Ethiopia; 2Department of Biochemistry, Division of Biomedical Sciences, University of Global Health Equity,...

Full description

Bibliographic Details
Main Authors: Muche Belete A, Seifu D, Menon M, Amogne W, Shewa A, Adela Tefera A
Format: Article
Language:English
Published: Dove Medical Press 2021-02-01
Series:HIV/AIDS: Research and Palliative Care
Subjects:
dyslipidemia
antiretroviral therapy
efavirenz
ritonavir-boosted atazanavir
Online Access:https://www.dovepress.com/serum-lipid-profiles-of-patients-taking-efavirenz-based-antiretroviral-peer-reviewed-article-HIV

Internet

https://www.dovepress.com/serum-lipid-profiles-of-patients-taking-efavirenz-based-antiretroviral-peer-reviewed-article-HIV

Similar Items